Latest Production Facilities News

Little Green Pharma Ltd (ASX:LGP) has secured overwhelming shareholder approval from Cannatrek Ltd for its proposed acquisition scheme, advancing the transaction toward Federal Court approval and implementation by early May 2026.

Orora has lowered its FY26 EBIT forecast for its Saverglass business due to direct operational impacts and indirect market shifts stemming from the ongoing Middle East conflict, while maintaining stable guidance for other segments.

6K Additive has commenced a major expansion of its Burgettstown facility, supported by a $23.4 million U.S. Defense Production Act grant and $31.4 million raised in its ASX IPO, aiming to increase production capacity five-fold by the end of 2026.

Prairie Lithium has secured a binding offtake agreement with Hydro Lithium for 100% of its Phase 1 lithium carbonate production, alongside a strategic AU$10 million equipment collaboration. This deal marks a significant milestone for Prairie’s Saskatchewan project, targeting first production in late 2026.

Little Green Pharma has issued a supplementary scheme booklet updating Cannatrek shareholders on the acquisition progress, including a revised timetable and the termination of a planned sale and leaseback of its WA production facility. Both companies’ boards continue to recommend the scheme, supported by an independent expert’s positive assessment.

NeuRizer Ltd has advanced its NeuRizer Urea Project with key environmental approvals and construction plans, while raising $350,000 through private placements. However, the company faces a trading suspension as it works to resolve audit and compliance issues with the ASX.

Andromeda Metals faces uncertainty in securing cornerstone funding for its Great White Project due to Middle East geopolitical tensions, while pushing forward with its High Purity Alumina pilot plant commissioning.

Nexsen Limited's subsidiary has won a HK$6 million grant to accelerate clinical validation and manufacturing of its rapid Group B Streptococcus diagnostic in Hong Kong, positioning the city as a key Asia-Pacific hub.

Pantera Minerals spotlights the launch of EnergyX’s Lonestar lithium demonstration plant in Texas, marking a key step towards a 50,000 tonne per annum lithium production target in the US.

Little Green Pharma has terminated its planned sale and leaseback of its Western Australian production facility after failing to reach commercial terms, choosing to retain ownership without impacting operations.

Evion Group is advancing the Stage 2 expansion of its expandable graphite facility in India to boost production capacity amid rising demand from Europe, the USA, and Asia. The upgrade aligns with the EU’s recognition of graphite as a critical mineral, positioning Evion as a key supplier in strategic sectors.

The US International Trade Commission has overturned preliminary findings and declined to impose steep tariffs on Chinese graphite anode materials, complicating Syrah Resources’ plans to scale up its US-based production facility.